577
Views
21
CrossRef citations to date
0
Altmetric
Review Article

The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target

Pages 48-61 | Published online: 13 Dec 2016

References

  • MorrowJDHillKEBurkRFNammourTMBadrKFRobertsLJd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanismProc Natl Acad Sci U S A19908793837
  • RobertsLJMorrowJD. Measurement of F2-isoprostanes as an index of oxidative stress in vivoFree Radic Biol Med20002850513
  • BasuS. F2-isoprostane induced prostaglandin formation in the rabbitFree Radic Res2006402737
  • BasuS. Isoprostanes: novel bioactive products of lipid peroxidationFree Radic Res20043810522
  • SamuelssonBDahlenSELindgrenJARouzerCASerhanCN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effectsScience198723711716
  • SerhanCN. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectinsCurr Opin Clin Nutr Metab Care2005811521
  • Basu S. Novel cyclooxygenase-catalysed bioactive prostaglandin F2α from physiology to new principles in inflammation Medicinal Research Reviews 2006; On-line published December 2006.
  • Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance Am J Clin Nutr 1993;57:715–24S; discussion 724–5S.
  • BasuS. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrientsToxicology200318911327
  • FinkelTHolbrookNJ. Oxidants, oxidative stress and the biology of ageingNature200040823947
  • FinkelT. Oxygen radicals and signalingCurr Opin Cell Biol19981024853
  • NishikawaTEdelsteinDDuXLMatsumauraTKanedaYYorekMA Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damageNature200040478790
  • BogdanC. Nitric oxide and the regulation of gene expressionTrends Cell Biol2001116675
  • NemotoSFinkelT. Ageing and the mystery at ArlesNature200442914952
  • NugterenDHVonkemanHvan DorfDA. Non-enzymatic conversion of all cis 8,11,14-eicosapentanoic acid into PGE1Recl Trav Chim Pays-bas19678612371245
  • PorterNAFunkMO. Letter: Peroxy radical cyclization as a model for prostaglandin biosynthesisJ Org Chem19754036145
  • MorrowJD. The isoprostanes: their quantification as an index of oxidant stress status in vivoDrug Metab Rev20003237785
  • MorrowJDAwadJABossHJBlairIARobertsLJ II. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipidsProc Natl Acad Sci U S A199289107215
  • SodergrenEVessbyBBasuS. Radioimmunological measurement of F2-isoprostanes after hydrolysis of lipids in tissuesProstaglandins Leukot Essent Fatty Acids20006314952
  • BasuSHelmerssonJ. Factors regulating isoprostane formation in vivoAntioxid Redox Signal2005722135
  • SodergrenECederbergJVessbyBBasuS. Vitamin E reduces lipid peroxidation in experimental hepatotoxicity in ratsEur J Nutr200140106
  • MorrowJDAwadJAKatoTTakahashiKBadrKFRobertsLJ Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidationJ Clin Invest19929025027
  • CasadesusGSmithMABasuSHuaJCapobiancoDESiedlakS Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer diseaseMol Neurodegener200722
  • LongmireAWSwiftLLRobertsLJ IIAwadJABurkRFMorrowJD. Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomesBiochem Pharmacol19944711737
  • BasuS. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicityBiochem Biophys Res Commun19992547647
  • HartCMKarmanRJBlackburnTLGuptaMPGarciaJGMohlerER III. Role of 8-epi PGF2α, 8-isoprostane, in H2O2-induced derangements of pulmonary artery endothelial cell barrier functionProstaglandins Leukot Essent Fatty Acids199858916
  • RichelleMTuriniMEGuidouxRTavazziIMetaironSFayLB. Urinary isoprostane excretion is not confounded by the lipid content of the dietFEBS Lett199945925962
  • HalliwellB. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?Cardiovasc Res2000474108
  • BasuS. Radioimmunoassay of 8-iso-prostaglandin F2α: an index for oxidative injury via free radical catalysed lipid peroxidationProstaglandins Leukot Essent Fatty Acids19985831925
  • WangZCiabattoniGCreminonCLawsonJFitzGeraldGAPatronoC Immunological characterization of urinary 8-epi-prostaglandin F2α excretion in manJ Pharmacol Exp Ther199527594100
  • AdiyamanMLawsonJAKhanapureSPFitzGeraldGARokachJ. Total synthesis of 17,17,18,18-d4-iPF2α-VI and quantification of iPF2α-VI in human urine by gas chromatography/mass spectrometryAnal Biochem19982624556
  • KadiiskaMBGladenBCBairdDDGermolecDGrahamLBParkerCE Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?Free Radic Biol Med200538698710
  • KadiiskaMBGladenBCBairdDDGrahamLBParkerCEAmesBN Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoningFree Radic Biol Med2005387118
  • WiklundLSharmaHSBasuS. Circulatory arrest as a model for studies of global ischemic injury and neuroprotectionAnn N Y Acad Sci2005105320519
  • BasuSLiuXNozariARubertssonSMiclescuAWiklundL. Evidence for time-dependent maximum increase of free radical damage and eicosanoid formation in the brain as related to duration of cardiac arrest and cardio-pulmonary resuscitationFree Radic Res2003372516
  • BasuSNozariALiuXLRubertssonSWiklundL. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrestFEBS Lett200047016
  • LiuXLNozariABasuSRonquistGRubertssonSWiklundL. Neurological outcome after experimental cardiopulmonary resuscitation: a result of delayed and potentially treatable neuronal injury?Acta Anaesthesiol Scand20024653746
  • LiuXLWiklundLNozariARubertssonSBasuS. Differences in cerebral reperfusion and oxidative injury after cardiac arrest in pigsActa Anaesthesiol Scand20034795867
  • IdrisAHRobertsLJ IICarusoLShowstarkMLayonAJBeckerLB Oxidant injury occurs rapidly after cardiac arrest, cardiopulmonary resuscitation, and reperfusionCrit Care Med20053320438
  • BasuSHellbergAUlusATWestmanJKaracagilS. Biomarkers of free radical injury during spinal cord ischemiaFEBS Lett2001508368
  • DelantyNReillyMPPraticoDMezzettiAFalcoASantaroneS 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivoCirculation19979524929
  • MiclescuABasuSWiklundL. Methylene blue added to hypertonic–hyperoncotic solution increases survival in experimental cardiac arrestCrit Care Med200634280616
  • DaviGCiabattoniGConsoliALawsonJAMcCarthyJFWoodAE In vivo formation of 8-iso-prostaglandin F2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementationCirculation1999992249
  • DaviGChiarelliFSantilliFPomilioMVigneriSFalcoA Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease durationCirculation20031073199203
  • O'ByrneSFortePRobertsLJ II Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretionDiabetes20004985762
  • VessbyJBasuSMohsenRBerneCVessbyB. Oxidative stress and antioxidant status in type 1 diabetes mellitusJ Intern Med20022516976
  • HoeldtkeRDBrynerKDMcNeillDRWarehimeSSVan DykeKHobbsG. Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetesJ Clin Endocrinol Metab20038816248
  • GleisnerAMartinezLPinoRRojasIGMartinezAAsenjoS Oxidative stress markers in plasma and urine of prepubertal patients with type 1 diabetes mellitusJ Pediatr Endocrinol Metab2006199951000
  • GopaulNKAnggardEEMalletAIBetteridgeDJWolffSPNourooz-ZadehJ. Plasma 8-epi-PGF2α levels are elevated in individuals with non-insulin dependent diabetes mellitusFEBS Lett19953682259
  • GopaulNKManrajMDHebeALee Kwai YanSJonstonACarrierMJ Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolismDiabetologia20014470612
  • MuraiYHishinumaTSuzukiNSatohJToyotaTMizugakiM. Determination of urinary 8-epi-prostaglandin F2α using liquid chromatography–tandem mass spectrometry: increased excretion in diabeticsProstaglandins Other Lipid Mediat20006217381
  • HelmerssonJVessbyBLarssonABasuS. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly populationCirculation2004109172934
  • DaviGAlessandriniPMezzettiAMinottiGBucciarelliTCostantiniF In vivo formation of 8-epi-prostaglandin F2α is increased in hypercholesterolemiaArterioscler Thromb Vasc Biol19971732305
  • ReillyMPPraticoDDelantyNDimminoGTremoliERaderD Increased formation of distinct F2 isoprostanes in hypercholesterolemiaCirculation19989828228
  • RobertsLJOatesJAFazioSGrossMLintonMMorrowJ. A-tocopherol supplementation reduces plasma F2-isoprostane concentrations in hypercholesterolemic humans only at doses of 800 IU or higherFree Radic Biol Med200233S412
  • RaalFJPilcherGJWaisbergRButheleziEPVellerMGJoffeBI Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemiaAm J Cardiol19998313303
  • CracowskiJLPloinDBessardJBraguetJPStanke-LabesqueFMallionJM Formation of isoprostanes in children with type IIa hypercholesterolemiaJ Cardiovasc Pharmacol20013822831
  • PraticoDIulianoLMaurielloASpaqnoliLLawsonJARokachJ Localization of distinct F2-isoprostanes in human atherosclerotic lesionsJ Clin Invest1997100202834
  • GniwottaCMorrowJDRobertsLJ IIKuhnH Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesionsArterioscler Thromb Vasc Biol199717323641
  • MehrabiMREkmekciogluCTatzberFOquoghoAUllrichAMorganA The isoprostane, 8-epi-PGF2α, is accumulated in coronary arteries isolated from patients with coronary heart diseaseCardiovasc Res1999434929
  • UlusATAksoyekAOzkanMKatirciogluSFBasuS Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humansFree Radic Biol Med2003349117
  • ReillyMPDelantyNRoyLRokachJCallaghanPOCreanP Increased formation of the isoprostanes IPF2α-I and 8-epi-prostaglandin F2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humansCirculation199796331420
  • BergKWisethRBjerveKBrurokHGunnesSSkaraS Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin releaseFree Radic Res20043851725
  • IulianoLPraticoDGrecoCMangichiEScibilliaGFitzGeraldGA Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCAJ Am Coll Cardiol2001377680
  • ShishehborMHZhangRMedinaHBrennanMLBrennanDMEllisSG Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery diseaseFree Radic Biol Med200641167883
  • CracowskiJLTremelFMarpeauC Increased formation of F2-isoprostanes in patients with severe heart failureHeart20008443940
  • MallatZPhilipILebretMChatelDMacloufJTedguiA Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failureCirculation19989715369
  • MorrowJDFreiBLongmireAWGazianoJMLynchSMShyrY Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damageN Engl J Med19953321198203
  • HelmerssonJLarssonAVessbyBBasuS Active smoking and a history of smoking are associated with enhanced prostaglandin F2α, interleukin-6 and F2-isoprostane formation in elderly menAtherosclerosis20051812017
  • AhmadzadehfarHOguoghoAEfthimiouYKritzHSinzingerH Passive cigarette smoking increases isoprostane formationLife Sci2006788947
  • MontuschiPCorradiMCiabattoniGNightingaleJKharitonovSABarnesPJ Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patientsAm J Respir Crit Care Med199916021620
  • WoodLGFitzgeraldDAGibsonPGCooperDMGargML Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthmaLipids20003596774
  • BaraldiEGhiroLPiovanVCarraroSCiabattoniGBarnesPJ Increased exhaled 8-isoprostane in childhood asthmaChest20031242531
  • CarpenterCTPricePVChristmanBW Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDSChest199811416539
  • CollinsCEQuaggiottoPWoodLO'LoughlinEVHenryRLGargML. Elevated plasma levels of F2α isoprostane in cystic fibrosisLipids1999345516
  • CiabattoniGDaviGColluraMIapichinoLPardoFGanchiA In vivo lipid peroxidation and platelet activation in cystic fibrosisAm J Respir Crit Care Med20001621195201
  • MontuschiPKharitonovSACiabattoniGCorradiMvan RensenLGeddesDM Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosisThorax2000552059
  • CracowskiJLCracowskiCBessardGPepinJLBessardJSchwebelC Increased lipid peroxidation in patients with pulmonary hypertensionAm J Respir Crit Care Med2001164103842
  • PraticoDBasiliSVieriMCordovaCVioliFFitzgeraldGA Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2α-III, an index of oxidant stressAm J Respir Crit Care Med1998158170914
  • MontuschiPCollinsJVCiabattoniGLazzeriNCorradiMKharitnovSA Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokersAm J Respir Crit Care Med200016211757
  • MontuschiPCiabattoniGParediPPantelidisPdu BoisRMKharitnovSA 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseasesAm J Respir Crit Care Med199815815247
  • MorrisJMGopaulNKEndresenMJKnightMLintonEADhirS Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsiaBr J Obstet Gynaecol199810511959
  • IshiharaOHayashiMOsawaHKobayashiKTakedaSVessbyB Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancyFree Radic Res2004389138
  • ReganCLLevineRJBairdDDEwellMGMartzKLSibaiBM No evidence for lipid peroxidation in severe preeclampsiaAm J Obstet Gynecol20011855728
  • WalshSWVaughanJEWangYRobertsLJ II Placental isoprostane is significantly increased in preeclampsiaFaseb J200014128996
  • BardenARitchieJWaltersBCroftKDWaltersBNMichaelCA Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsiaHypertension2001388038
  • BardenABeilinLJRitchieJCroftKDWaltersBNMichaelCA Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancyClin Sci (Lond)1996917118
  • PerroneSLonginiMBellieniCV Early oxidative stress in amniotic fluid of pregnancies with Down syndromeClin Biochem20074017780
  • MontineTJBealMFCudkowiczMEO'DonnelHMargolinRAMcFarlandL Increased CSF F2-isoprostane concentration in probable ADNeurology1999525625
  • MontineTJMarkesberyWRZackertWSanchezSCRobertsLJ IIMorrowJD The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patientsAm J Pathol19991558638
  • PraticoDClarkCMLeeVMTrojanowskiJQRokachJFitzGeraldGA Increased 8,12-iso-iPF2α-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severityAnn Neurol20004880912
  • Feillet-CoudrayCTourtauchauxRNiculescuMRockETauveronIAlexandre-GouabauMC Plasma levels of 8-epiPGF2α, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's diseaseFree Radic Biol Med1999274639
  • MontineTJQuinnJFMilatovicDSilbertLCDaugTSanchezS Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's diseaseAnn Neurol2002521759
  • MontineTJShinobuLMontineKSRobertsII LJKnowallNWBealMF No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controlsAnn Neurol200048950
  • MontineTJBealMFRobertsonDCudkowiczMEBiaggioniIO'DonnellD Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's diseaseNeurology19995211045
  • FesselJPHuletteCPowellSRobertsLJ IIZhangJ Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body diseaseJ Neurochem20038564550
  • HelmerssonJMattssonPBasuS Prostaglandin F2α metabolite and F2-isoprostane excretion rates in migraineClin Sci (Lond)20021023943
  • MongaMDunnKRajasekaranM Characterization of ultrastructural and metabolic abnormalities in semen from men with spinal cord injuryJ Spinal Cord Med200124416
  • MattssonNHaghighiSAndersenOYaoYRosengrenLBrennowK Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patientsNeurosci Lett20074142336
  • Camphausen K, Ménard C, Sproull M, Goley E, Basu S, Coleman C. Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated J Radiation Oncology, Biology, Physics 2003; 58: 1536–9.
  • HandelmanGJWalterMFAdhikarlaRGrossJDallalGELevinNW Elevated plasma F2-isoprostanes in patients on long-term hemodialysisKidney Int20015919606
  • IkizlerTAMorrowJDRobertsLJEvansonJABeckerBHakimRM Plasma F2-isoprostane levels are elevated in chronic hemodialysis patientsClin Nephrol2002581907
  • CracowskiJLSouvignetCQuirinNGrosbisVBayleFStanke-LabesqueF Urinary F2-isoprostanes formation in kidney transplantationClin Transplant2001155862
  • Basu S, Meisert I, Eggensperger E, Krieger E, Krenn CG. Time course attenuation of ischemia–reperfusion injury by propofol in human renal transplantation Redox Report in press.
  • LauzuricaRPastorMCBayesBHernandezJMBonetJLlopisMA F2-isoprostanes in kidney transplant patients: relationship with inflammatory markersTransplant Proc20053738423
  • MinuzPPatrignaniPGainoSDeganMMenapaceLTommsoliR Increased oxidative stress and platelet activation in patients with hypertension and renovascular diseaseCirculation200210628005
  • BasuSWhitemanMMatteyDLHalliwellB Raised levels of F2-isoprostanes and prostaglandin F2α in different rheumatic diseasesAnn Rheum Dis20016062731
  • CracowskiJLMarpeauCCarpentierPHImbertBCachotSStanke-LabesqueF Enhanced in vivo lipid peroxidation in scleroderma spectrum disordersArthritis Rheum20014411438
  • SteinCMTannerSBAwadJARobertsLJ IIMorrowJD Evidence of free radical-mediated injury (isoprostane overproduction) in sclerodermaArthritis Rheum199639114650
  • WolframRMBudinskyACEderAPresenhuberCNellASperrW Salivary isoprostanes indicate increased oxidation injury in periodontitis with additional tobacco abuseBiofactors2006282131
  • SinzingerHKalimanJOguoghoA Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokersLymphology2000332431
  • MontineTJSidellKRCrewsBCMarkesberyWRMarnettLJRobertsLJ Elevated CSF prostaglandin E2 levels in patients with probable ADNeurology19995314958
  • Pratico D, V MYL, Trojanowski JQ, Rokach J, Fitzgerald GA. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo Faseb J 1998;12:1777–83.
  • Feillet-CoudrayCTourtauchauxRNiculescuMRockETauveronIAlexandre-GouabauMC Plasma levels of 8-epiPGF2α, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's diseaseFree Radic Biol Med1999274639
  • BasuSMichaelssonKOlofssonHJohanssonSMelhusH Association between oxidative stress and bone mineral densityBiochem Biophys Res Commun20012882759
  • SinaikoARSteinbergerJMoranAPrineasRJVessbyBBasuS Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescenceCirculation2005111198591
  • PraticoDTangiralaRKRaderDJRokachJFitzGeraldGA Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient miceNat Med19984118992
  • MeagherEABarryOPLawsonJARokachJFitzGeraldGA Effects of vitamin E on lipid peroxidation in healthy personsJAMA2001285117882
  • SmedmanAVessbyBBasuS Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitorClin Sci (Lond)20041066773
  • PatrignaniPPanaraMRTacconelliSSetaFBucciarelliTCiabattoniG Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokersCirculation200010253945
  • WeinbergRBVanderWerkenBSAndersonRAStegnerJEThomasMJ Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat dietArterioscler Thromb Vasc Biol200121102933
  • DaviGDi MinnoGCoppolaAAndriaGCerboneAMMadonnaP Oxidative stress and platelet activation in homozygous homocystinuriaCirculation200110411248
  • MeagherEABarryOPBurkeALuccyMRLawsonJARokachJ Alcohol-induced generation of lipid peroxidation products in humansJ Clin Invest199910480513
  • Basu S, Lee R, Dunster C, Kelly FJ. Lipid peroxidation biomarker changes in humans in response to increasing doses of α-tocopherol Proc NY Acad Sci 2004;P12.
  • SteinbergD Low density lipoprotein oxidation and its pathobiological significanceJ Biol Chem1997272209636
  • LoscalzoJ Oxidative stress in endothelial cell dysfunction and thrombosisPathophysiol Haemost Thromb20023235960
  • SteinbergDWitztumJL Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?Circulation2002105210711
  • SteinbergD Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crimeNat Med2002812117
  • VivekananthanDPPennMSSappSKHsuATopolEJ Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trialsLancet2003361201723